---
title: "Microbiome Profiling Identifies Prognostic Heterogeneity in Staphylococcus aureus Pneumonia"
id: "medrxiv-18-microbiome-profiling-reveals-prognostic-heterogeneity-in-staphylococcus-aureus"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-18-microbiome-profiling-reveals-prognostic-heterogeneity-in-staphylococcus-aureus"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.17.26363347v1?rss=1"
published_at: "2026-09-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Microbiome Profiling Identifies Prognostic Heterogeneity in Staphylococcus aureus Pneumonia
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-18-microbiome-profiling-reveals-prognostic-heterogeneity-in-staphylococcus-aureus
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.17.26363347v1?rss=1)
- **Published At:** 2026-09-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Study of mechanically ventilated, culture-confirmed **Staphylococcus aureus** pneumonia evaluated lower respiratory tract microbiome using **16S rRNA gene sequencing** and shotgun **nanopore metagenomics**. - 109 patients were included overall; 16S sequencing was performed on 54 endotracheal aspirates and nanopore metagenomics on 28 samples. - Culture semi-quantitative growth and methicillin resistance were not associated with 60-day outcomes in this cohort. - **Staphylococcus** relative abundance by 16S varied widely (0–96.7%); only 33% of sequenced samples showed **dominance** (>50% relative abundance). - Dominance correlated with worse 60-day survival (50% vs 80%, p=0.013) and remained independently predictive after adjustment (adjusted HR 3.24, 95% CI 1.12–9.36, p=0.030). - High absolute S. aureus read counts by nanopore sequencing independently predicted mortality (adjusted HR 11.23, 95% CI 2.25–55.9, p=0.003). - Dominant Staphylococcus phenotype associated with elevated pentraxin-3 (p=0.01) and lower fractalkine (p=0.02), indicating a dysregulated host response. - Exploratory virulence gene analysis (n=19) linked detection of **staphylokinase** to a hyperinflammatory phenotype (p=0.003) and to higher mortality (p=0.046). - Authors conclude conventional culture positivity conceals clinically meaningful heterogeneity; **microbiome** and metagenomic profiling can identify a high-risk, high-burden phenotype not captured by routine diagnostics.
## Clinical Analysis & Structured Key Points
Microbiome Profiling Reveals Prognostic Heterogeneity in Staphylococcus aureus Pneumonia | medRxiv Skip to main content Microbiome Profiling Reveals Prognostic Heterogeneity in Staphylococcus aureus Pneumonia View ORCID Profile Georgios Kitsios , Michael Aaron Sy , View ORCID Profile William G. Bain , Matthew Hensley , Shulin Qin , Xiaohong Wang , Kyle W. Inman , Charles Dela Cruz , Keven Robinson , Seyed Mehdi Nouraie , Faraaz A. Shah , View ORCID Profile Panayiotis Benos , Bryan J. McVerry , Alison Morris doi: https://doi.org/10.64898/2026.09.17.26363347 Georgios Kitsios 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Georgios Kitsios For correspondence: georgios.kitsios1{at}gmail.com Michael Aaron Sy 2 University of Florida; Find this author on Google Scholar Find this author on PubMed Search for this author on this site William G. Bain 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for William G. Bain Matthew Hensley 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Shulin Qin 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Xiaohong Wang 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kyle W. Inman 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Charles Dela Cruz 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Keven Robinson 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Seyed Mehdi Nouraie 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Faraaz A. Shah 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Panayiotis Benos 2 University of Florida; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Panayiotis Benos Bryan J. McVerry 1 University of Pittsburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alison Morris 3 Rutgers Robert Wood Johnson Medical School Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background: Staphylococcus aureus is a leading cause of severe pneumonia in mechanically ventilated patients. Clinical cultures identify pathogen presence but may not reflect lower respiratory tract microbial ecology. Whether culture-confirmed S. aureus pneumonia encompasses compositional heterogeneity with prognostic implications remains unknown. Methods: We performed 16S rRNA gene sequencing and shotgun nanopore metagenomics on endotracheal aspirate samples from mechanically ventilated patients with culture-confirmed S. aureus pneumonia in a prospective ICU registry. We quantified Staphylococcus abundance, assessed correlations with culture characteristics and host inflammatory biomarkers, and examined associations with 60-day mortality using Kaplan-Meier and Cox hazards analyses. Results: Among 109 patients, semi-quantitative culture growth and methicillin resistance showed no associations with outcomes. 16S sequencing (n=54) revealed marked heterogeneity in Staphylococcus relative abundance (range 0-96.7%), with only 33% demonstrating dominance (>50%). Dominance was associated with worse 60-day survival (50% vs. 80%,p=0.013) and remained independently predictive after adjusting for age, sex, and methicillin resistance (adjusted HR 3.24 [95%CI 1.12-9.36],p=0.030). Patients with dominance exhibited elevated pentraxin-3 (p=0.01) and reduced fractalkine (p=0.02). Nanopore metagenomics (n=28) validated these findings, with high absolute S. aureus read counts independently predicting mortality (adjusted HR 11.23 [95%CI 2.25-55.9],p=0.003). In an exploratory analysis of virulence genes (n=19), staphylokinase detection was associated with the hyperinflammatory phenotype (p=0.003) and mortality (p=0.046). Conclusions: Metagenomic profiling reveals clinically meaningful heterogeneity within culture-confirmed S. aureus pneumonia, masked by conventional diagnostics. Staphylococcus dominance identifies a high-risk phenotype with elevated bacterial burden, dysregulated host responses, and increased mortality, challenging the assumption that culture positivity represents a uniform clinical entity. Competing Interest Statement Conflicts of Interest: GDK has received research funding from Pfizer, Inc., and Genentech, Inc., has received consulting fees from InflaRx, Inc, and serves on the Advisory Board for KeepBio, Inc. BJM has received research funding from Genentech, Inc. SMN has received funding from Pfizer, Inc and Genentech, Inc. AM has received research funding from Pfizer, Inc. All other authors disclosed no conflict of interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: University of Pittsburgh IRB I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Data Availability Statement: The 16S rRNA gene amplicon sequencing data analyzed in this study are deposited in the NCBI Sequence Read Archive under BioProject accession PRJNA595346, available at https://www.ncbi.nlm.nih.gov/bioproject/PRJNA595346. Nanopore metagenomic sequencing data are deposited under BioProject accession PRJNA554461, available at https://www.ncbi.nlm.nih.gov/bioproject/PRJNA554461. De-identified clinical metadata and derived analytic datasets, together with the analysis code used to generate the tables and figures in this manuscript, are available at [GitHub repository URL]. Raw clinical data are not publicly available due to institutional data use restrictions but may be made available by the corresponding author upon reasonable request and execution of an appropriate data use agreement. Funder Information Declared American Lung Association, https://ror.org/01p3rh655 National Heart Lung and Blood Institute , 5P01 HL114453 , R01 HL176668), , R21 HL168070 National Institute of General Medical Sciences , R01 GM141081 , R35 GM160146 BugSeq Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted September 20, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Microbiome Profiling Reveals Prognostic Heterogeneity in Staphylococcus aureus Pneumonia Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Microbiome Profiling Reveals Prognostic Heterogeneity in Staphylococcus aureus Pneumonia Georgios Kitsios , Michael Aaron Sy , William G. Bain , Matthew Hensley , Shulin Qin , Xiaohong Wang , Kyle W. Inman , Charles Dela Cruz , Keven Robinson , Seyed Mehdi Nouraie , Faraaz A. Shah , Panayiotis Benos , Bryan J. McVerry , Alison Morris medRxiv 2026.09.17.26363347; doi: https://doi.org/10.64898/2026.09.17.26363347 Share This Article: Copy Citation Tools Microbiome Profiling Reveals Prognostic Heterogeneity in Staphylococcus aureus Pneumonia Georgios Kitsios , Michael Aaron Sy , William G. Bain , Matthew Hensley , Shulin Qin , Xiaohong Wang , Kyle W. Inman , Charles Dela Cruz , Keven Robinson , Seyed Mehdi Nouraie , Faraaz A. Shah , Panayiotis Benos , Bryan J. McVerry , Alison Morris medRxiv 2026.09.17.26363347; doi: https://doi.org/10.64898/2026.09.17.26363347 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Infectious Diseases (except HIV/AIDS) Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4828) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15974) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7064) Geriatric Medicine (734) Health Economics (1066) Health Informatics (5060) Health Policy (1436) Health Systems and Quality Improvement (1775) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16304) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7290) Nursing (368) Nutrition (1084) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3614) Ophthalmology (1055) Orthopedics (398) Otolaryngology (457) Pain Medicine (472) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (739) Primary Care Research (768) Psychiatry and Clinical Psychology (5918) Public and Global Health (9770) Radiology and Imaging (2431) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1250) Rheumatology (642) Sexual and Reproductive Health (773) Sports Medicine (579) Surgery (782) Toxicology (107) Transplantation (305) Urology (293)
## Related Clinical Research

- [Understanding Parasitic Identification in Delusional Parasitosis](https://medichelpline.com/clinical-feed/plos-one-21-bridging-perception-and-reality-parasitic-identification-in-delusional.md)
- [Community-based mpox seroprevalence study in Manitoba and Alberta: evidence of undocumented exposu](https://medichelpline.com/clinical-feed/medrxiv-17-community-based-assessment-of-mpox-seroprevalence-and-undocumented-exposures-in.md)
- [Impact of mass oral cholera vaccination in Uvira, DRC: surveillance-based counterfactual analysis](https://medichelpline.com/clinical-feed/medrxiv-13-impact-of-mass-oral-cholera-vaccination-in-an-endemic-area-of-the-democratic.md)
- [Kennedy renews attacks on vaccines at Children’s Health Defense conference](https://medichelpline.com/clinical-feed/stat-news-1-kennedy-renews-attacks-on-vaccines-at-children-s-health-defense-conference.md)
- [Study says purer fentanyl won’t by itself explain U.S. overdose death decline](https://medichelpline.com/clinical-feed/stat-news-2-purer-fentanyl-won-t-solve-the-u-s-overdose-death-crisis-study-says.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.